Advancing human-use experience for real-world evidence for the registration of traditional Chinese medicine products in China
Abstract Background The registration application of traditional Chinese medicine (TCM) products as new drugs often meets the challenges of lacking clinical evidence from randomized controlled trials (RCT). In recent years, China has introduced a new evidence system for the review and approval of TCM...
Saved in:
| Main Authors: | Mingge Xia, Yan Xue, Luwei Zhu, Xianwen Chen, Carolina Oi Lam Ung, Sheng Han, Yunfeng Lai, Hao Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Complementary Medicine and Therapies |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12906-025-04906-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research on Application of Medical Device Real-World Evidence in Regulatory Decisions of the United States
by: Xiaofang GU, et al.
Published: (2025-07-01) -
Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine products
by: Chieko Ishiguro, et al.
Published: (2025-12-01) -
Use of real-world data as pivotal evidence in veterinary regulatory applications
by: Raffaele Bruno
Published: (2025-06-01) -
Erratum: Real-world evidence (RWE): a challenge for regulatory agencies discussion of the RWE conference with the network of the European medicine agencies, patients, and experts
by: Frontiers Production Office
Published: (2025-04-01) -
Chinese experience on using RWE to support drug research, development and evaluation
by: A. S. Kolbin, et al.
Published: (2022-01-01)